About this item:

25 Views | 23 Downloads

Author Notes:

Tamson Moore, Room 302, 2160 S. 1rst Avenue, Maywood, IL 60153, USA. Phone: (708) 327-3188. tamoore@luc.edu. ORCID: 0000-0003-3770-3503

Subjects:

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Oncology
  • Immunology

Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells (vol 67, pg 311, 2018)

Show all authors Show less authors

Tools:

Journal Title:

CANCER IMMUNOLOGY IMMUNOTHERAPY

Volume:

Volume 67, Number 2

Publisher:

, Pages 327-327

Type of Work:

Article | Post-print: After Peer Review

Abstract:

The authors would like to make the following corrections to the published article.Prior therapy for Patient 3 was high-dose IL-2, vemurafenib, ipilimumab, and dabrafenib (Table 1).TIL 1383I TCR complexes were tethered to the CM5 sensor surface and HLA-A2-tyrosinase complexes were injected over the surface (Methods and Fig. 5). The solution (3D) affinity of the TIL 1383I TCR was 13 μM (Fig. 5a and text).
Export to EndNote